The Antidepressant Web: Marketing depression and making medicines work
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
This paper was conceived as chapters two and three of the still unwritten book, and as a basis for discussion on an Internet website and elsewhere. These chapters examine hard evidence relating to a wholly rhetorical and hypothetical question, "Do antidepressants work?" The question provides the broadest possible framework for looking at the meaning and values of medicine. Implicitly, the question also asks: what is better than nothing, and how much better are antidepressant drugs than the placebos they are compared with in clinical trials? Between the lines of the paper lie basic questions about the ethics, activities, performance and impact of the three main centres of power in medicine - government, professionals and the pharmaceutical industry. The underlying issue is whether people who are miserably unfulfilled, sad, anguished or depressed are in hands as safe as they might imagine or need.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
A History of Psychiatry: From the Era of the Asylum to the Age of Prozac.
Herman, E., & Shorter, E. (1997) · The Journal of American History · doi:10.2307/2953108 · Cited by 1,056
Hirschfeld, R. M. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540280071036 · Cited by 895
Drugs and the treatment of psychiatric disorders
Baldessarini, R. J. (1996) · Medical Entomology and Zoology · Cited by 683
Recognition and management of depression in general practice: consensus statement
Paykel, E. S., & Priest, R. G. (1992) · BMJ · doi:10.1136/bmj.305.6863.1198 · Cited by 540
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399
Priest, R. G., Vize, C., Roberts, A., Roberts, M., & Tylee, A. (1996) · BMJ · doi:10.1136/bmj.313.7061.858 · Cited by 385
Withdrawal from long-term benzodiazepine treatment
Petursson, H., & Lader, M. H. (1981) · BMJ · doi:10.1136/bmj.283.6292.643 · Cited by 367
[Long-term treatment of depression].
Keller, M. B. (1994) · PubMed · Cited by 362
Jick, S. S., Dean, A. D., & Jick, H. (1995) · BMJ · doi:10.1136/bmj.310.6974.215 · Cited by 249
The treatment of depression: prescribing patterns of antidepressants in primary care in the UK
Donoghue, J. M., & Tylee, A. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.168.2.164 · Cited by 209
Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression
Montgomery, S. A., & Dunbar, G. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300830-00009 · Cited by 188
Antidepressant Drugs and the Emergence of Suicidal Tendencies
Teicher, M. H., Glod, C. A., & Cole, J. O. (1993) · Drug Safety · doi:10.2165/00002018-199308030-00002 · Cited by 169
BENZODIAZEPINES: USE, OVERUSE, MISUSE, ABUSE?
(1973) · The Lancet · doi:10.1016/s0140-6736(73)90405-4 · Cited by 165
Prozac Nation: Young and Depressed in America
Marlan, D., Wurtzel, E., & Kaysen, S. (1996) · Chicago Review · doi:10.2307/25306033 · Cited by 146
Addiction: brain mechanisms and their treatment implications
Nutt, D. J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91561-5 · Cited by 126
Treatment of Anxiety States by Antidepressant Drugs
Sargant, W., & Dally, P. (1962) · BMJ · doi:10.1136/bmj.1.5270.6 · Cited by 122
Drugs in the Treatment of Depression
Sargant, W. (1961) · BMJ · doi:10.1136/bmj.1.5221.225 · Cited by 121
Fluoxetine Hydrochloride (Prozac) Toxicity in a Neonate
SPENCER, M. J. (1993) · Pediatrics · doi:10.1542/peds.92.5.721 · Cited by 120
The Lancet's statistical review process: areas for improvement by authors
Gore, S. M., Jones, G., & Thompson, S. G. (1992) · The Lancet · doi:10.1016/0140-6736(92)90409-v · Cited by 88
Clinical Use of Psychotherapeutic Drugs
Hollister, L. E. (1970) · Postgraduate Medicine · doi:10.1080/00325481.1970.11698099 · Cited by 86
Antidepressant Withdrawal Syndromes: Phenomenology and Pathophysiology
DILSAVER, S. C., GREDEN, J. F., & SNIDER, R. M. (1987) · International Clinical Psychopharmacology · doi:10.1097/00004850-198701000-00001 · Cited by 81
Depressive Illness in a General Practice. A Demographic Study and a Controlled Trial of Imipramine
Porter, A. M. W. (1970) · BMJ · doi:10.1136/bmj.1.5699.773 · Cited by 77 · cited 1×
“(Porter, 1970) There are two ways of looking at placebos.”
BackgroundThe Benzodiazepines – for Good or Evil
Marks, J. (1983) · Neuropsychobiology · doi:10.1159/000117997 · Cited by 70
Drugs of Dependence Though Not of Abuse: Fenfluramine and Imipramine
Oswald, I., Lewis, S. A., Dunleavy, D. L. F., Brezinova, V., & Briggs, M. (1971) · BMJ · doi:10.1136/bmj.3.5766.70 · Cited by 68
Anxiety symptom relief in depression treatment outcomes.
Keller, M. B., & Hanks, D. L. (1995) · PubMed · Cited by 65
Suspected congenital sertraline dependence
Kent, L., & Laidlaw, J. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.167.3.412b · Cited by 64
The Marketing of5-Hydroxytryptamine: Depression or Anxiety?
Healy, D. (1991) · The British Journal of Psychiatry · doi:10.1192/bjp.158.6.737 · Cited by 60
Therapeutic Efficacy of Antidepressant Drugs: A Review
Cole, J. O. (1964) · JAMA · doi:10.1001/jama.1964.03070180046007 · Cited by 60
Fluvoxamine withdrawal syndrome
Szabadi, E. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.160.2.283b · Cited by 58
Adverse events after the abrupt discontinuation of paroxetine
Dominguez, R. A., & Goodnick, P. J. (1995) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb02896.x · Cited by 57
Studies on the effectiveness of antidepressant drugs.
Smith, A. J., Traganza, E., & Harrison, G. (1969) · PubMed · Cited by 56
Are placebo run ins justified?
Senn, S. J. (1997) · BMJ · doi:10.1136/bmj.314.7088.1191 · Cited by 52
Efficacy in long-term treatment of depression.
Montgomery, S. A. (1996) · PubMed · Cited by 50
Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors
Frost, L., & Lal, S. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.5.810a · Cited by 49
Withdrawal Syndromes After Paroxetine and Sertraline Discontinuation
Fava, G. A., & Grandi, S. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199510000-00012 · Cited by 46
Severe psychiatric symptoms associated with paroxetine withdrawal
Bloch, M., Stager, S., Braun, A., & Rubinow, D. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92691-7 · Cited by 45
Possible venlafaxine withdrawal syndrome
Farah, A., & Lauer, T. E. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.4.576a · Cited by 42
Discontinuation reactions following sertraline
Leiter, F. L., Nierenberg, A. A., Sanders, K. M., & Stern, T. A. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00311-8 · Cited by 40
A possible paroxetine withdrawal syndrome
Phillips, S. D. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.4.645b · Cited by 39
Antidepressant prescribing: a comparison between general practitioners and psychiatrists.
Kerr, M. (1994) · Europe PMC (PubMed Central) · Cited by 37
Are Antidepressants Better Than Placebo?
Malitz, S., & Kanzler, M. (1971) · American Journal of Psychiatry · doi:10.1176/ajp.127.12.1605 · Cited by 35
The Practical Management of Depression
Kline, N. S. (1964) · JAMA · doi:10.1001/jama.1964.03070210038007 · Cited by 34
Venlafaxine withdrawal reactions
Louie, A. K., Lannon, R. A., Kirsch, M. A., & Lewis, T. B. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.12.1652a · Cited by 33
Placebo-controlled efficacy of antidepressants in continuation treatment
Montgomery, S. A., Roberts, A., & Patel, A. G. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00008 · Cited by 32
Paroxetine withdrawal syndrome
Pyke, R. E. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.1.149b · Cited by 31
A CRITICAL LOOK AT ANTIDEPRESSANT DRUG TRIALS
LEYBURN, P. (1967) · The Lancet · doi:10.1016/s0140-6736(67)90635-6 · Cited by 30
Improving the Management and Knowledge of Depression
Priest, R. G. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.3.285 · Cited by 27
Power and dependence: Social audit on the safety of medicines
Medawar, C., Rassaby, E., & Güthrie, B. (1992) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 27
Self-citationVenlafaxine Withdrawal Symptoms
Benazzi, F. (1996) · The Canadian Journal of Psychiatry · doi:10.1177/070674379604100722 · Cited by 26
Reversible delirium after discontinuation of fluoxetine.
Kasantikul, D. (1995) · PubMed · Cited by 26
ANTIDEPRESSANTS IN LONG-TERM TREATMENT
Montgomery, M. D. (1994) · Annual Review of Medicine · doi:10.1146/annurev.med.45.1.447 · Cited by 25
Fluoxetine withdrawal symptoms.
Berlin, C. S. (1996) · PubMed · Cited by 24
Sertraline withdrawal in two brothers: a case-report
Rosenstock, H. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199603000-00009 · Cited by 19
Adverse drug reactions/interactions in maintenance therapy.
Gd, T. (1993) · PubMed · Cited by 18
The Power to Harm: Mind, Medicine, and Murder on Trial
Cornwell, J. K. (1996) · DigitalGeorgetown (Georgetown University Library) · Cited by 9
Through the doors of deception?
Medawar, C. (1994) · Nature · doi:10.1038/368369a0 · Cited by 9
Self-citationSymptoms of major depression: acute effect of withdrawing antidepressants
Halle, M. T., Medico, V. J. D., & Dilsaver, S. C. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb05531.x · Cited by 8
Fullerton, A., & Boardman, R. H. (1959) · The Lancet · doi:10.1016/s0140-6736(59)91225-5 · Cited by 7
Recent Clinical Development With Reversible and Selective Amine Oxidase Inhibitors
Priest, R. G. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199508001-00001 · Cited by 6
Benzodiazepine dependence: Who is responsible?
Hallstrüm, C. (1991) · Journal of Forensic Psychiatry · doi:10.1080/09585189108408611 · Cited by 3
LONG TERM TREATMENT WITH SSRIs
Montgomery, S. (1992) · Clinical Neuropharmacology · doi:10.1097/00002826-199201001-00235 · Cited by 3
Update on antidepressant therapy.
Preskorn, S. H. (1994) · PubMed · Cited by 3
Dc, M. (1995) · PubMed · Cited by 3
ECT clinics are below standard
Wise, J. (1997) · BMJ · doi:10.1136/bmj.314.7076.247d · Cited by 2
Cited by
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Antidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Martinez, C., Rietbrock, S., Wise, L., Ashby, D., Chick, J., Moseley, J., Evans, S., & Gunnell, D. (2005) · BMJ · doi:10.1136/bmj.330.7488.389 · Cited by 240
Can long-term treatment with antidepressant drugs worsen the course of depression?
Fava, G. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0204 · Cited by 223
The mechanisms of tolerance in antidepressant action
Fava, G. A., & Offidani, E. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.026 · Cited by 158
“They have been described with any type of antidepressant drugs (Dilsalver, 1990), and particularly MAO inhibitors and SSRI (Lejoyeux et al., 1996; Zajecka et al., 1997; Medawar, 1997; Oliver et al., 1999; Rosenbaum et al., 1998).”
Metadata
- Authors
- Medawar, C.
- Affiliations
- Social Audit Ltd., P.O. Box 111, London NWI 8XG, UK
- Corresponding author
- Medawar, Charles
- Venue
- International Journal of Risk and Safety in Medicine
- Publisher
- SAGE Publications
- Published
- 1997
- Volume
- 10
- Issue
- 2
- Pages
- 75-126
- ISSN
- 0924-6479 (ISSN-L)
- OpenAlex
- W2280939070
- Cited by
- 92
- References
- 65
- Citations by year
- 2024: 1 · 2022: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2016: 1 · 2015: 3 · 2013: 14
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Risk & Safety in Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- antidepressants, antidepressant efficacy, placebo comparison, clinical trials, medical ethics, pharmaceutical industry, government regulation of medicine, medical professionals, patient safety, depression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.